11th Circuit Hears Arguments In False Advertising Suit Over Epinephrine Labels
MIAMI — Two pharmaceutical companies on April 20 engaged in oral arguments before the 11th Circuit U.S. Court of Appeals over whether the purported false implication that a drug has been...To view the full article, register now.
Already a subscriber? Click here to view full article